Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: The PRIME study

International Journal of Cardiology

Volumn 108, Issue 2, 2006, Pages 189-196

  Bataille, Vincent ^a   Perret, Bertrand ^b   Troughton, Judith ^c   Amouyel, Philippe ^d   Arveiler, Dominique ^e   Woodside, Jayne ^c   Dallongeville, Jean ^d   Haas, Bernadette ^e   Bingham, Annie ^a   Ducimetière, Pierre ^a   Ferrières, Jean ^a  

^a INSERM   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

CHD; Insulin; Male; Middle aged; Prospective; Risk

Indexed keywords

INSULIN;

ADULT; ANTHROPOMETRY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; FRANCE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; INCIDENCE; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REFERENCE VALUE; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

EID: 33644696119     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.04.024     Document Type: Article

References (34)

1. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
2. S.M. Haffner Insulin resistance, inflammation, and the prediabetic state Am J Cardiol 92 2003 18J 26J
3. M.C. Alessi, I. Juhan-Vague, T. Kooistra, P.J. Declerck, and D. Collen Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2 Thromb Haemost 60 1988 491 494
4. I. Juhan-Vague, S.G. Thompson, and J. Jespersen Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group Arterioscler Thromb 13 1993 1865 1873
5. J.B. Meigs, M.A. Mittleman, and D.M. Nathan Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study JAMA 283 2000 221 228
6. A. Festa, A.J. Hanley, R.P. Tracy, R. D'Agostino Jr., and S.M. Haffner Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion Circulation 108 2003 1822 1830
7. P. Marques-Vidal, E. Mazoyer, and V. Bongard Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers Diabetes Care 25 2002 1371 1377
8. E. Eschwege, J.L. Richard, and N. Thibult Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later Horm Metab Res Suppl 15 1985 41 46
9. K. Pyorala, E. Savolainen, S. Kaukola, and J. Haapakoski Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen study population Acta Med Scand Suppl 701 1985 38 52
10. L.F. Moller, and J. Jespersen Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up J Cardiovasc Risk 2 1995 235 240
11. J.P. Despres, B. Lamarche, and P. Mauriege Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
12. J.P. Despres, I. Lemieux, and A.C. St-Pierre Hyperinsulinemia and ischemic heart disease risk in men: 13-year follow-up data of the Québec Cardiovascular Study. Scientific sessions of the American Heart Association. November 7-10, 2004, New Orleans, Louisiana (USA) Circulation 110 17 suppl III 2004 772
13. L. Welin, H. Eriksson, B. Larsson, L.O. Ohlson, K. Svardsudd, and G. Tibblin Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913 Diabetologia 35 1992 766 770
14. T.J. Orchard, J. Eichner, L.H. Kuller, D.J. Becker, L.M. McCallum, and G.A. Grandits Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the multiple risk factor intervention trial Ann Epidemiol 4 1994 40 45
15. A. Ferrara, E.L. Barrett-Connor, and S.L. Edelstein Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991 Am J Epidemiol 140 1994 857 869
16. J.B. Ruige, W.J. Assendelft, J.M. Dekker, P.J. Kostense, R.J. Heine, and L.M. Bouter Insulin and risk of cardiovascular disease: a meta-analysis Circulation 97 1998 996 1001
17. J.Y. Oh, E. Barrett-Connor, and N.M. Wedick Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study Circulation 105 2002 1311 1316
18. B. Lindahl, B. Dinesen, and M. Eliasson High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population Metabolism 48 1999 1197 1202
19. J.S. Yudkin, M. May, P. Elwood, J.W. Yarnell, R. Greenwood, and G. Davey Smith Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly study Diabetologia 45 2002 327 336
20. B. Zethelius, L. Byberg, C.N. Hales, H. Lithell, and C. Berne Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study Circulation 105 2002 2153 2158
21. J.W. Yarnell The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective epidemiological study of myocardial infarction QJM 91 1998 667 676
22. G. Luc, J.M. Bard, and I. Juhan-Vague C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study Arterioscler Thromb Vasc Biol 23 2003 1255 1261
23. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
24. D.J. Schneider, T.K. Nordt, and B.E. Sobel Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells Diabetes 41 1992 890 895
25. T.K. Nordt, D.J. Schneider, and B.E. Sobel Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease Circulation 89 1994 321 330
26. A. Festa, R. D'Agostino Jr., and L. Mykkanen Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS) Arterioscler Thromb Vasc Biol 19 1999 562 568
27. S.M. Haffner Epidemiology of insulin resistance and its relation to coronary artery disease Am J Cardiol 84 1999 11J 14J
28. M. Pyorala, H. Miettinen, M. Laakso, and K. Pyorala Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Stroke 29 1998 1860 1866
29. B.B. Kahn Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance Cell 92 1998 593 596
30. R.A. DeFronzo, R.C. Bonadonna, and E. Ferrannini Pathogenesis of NIDDM. A balanced overview Diabetes Care 15 1992 318 368
31. S. Del Prato, and A. Tiengo The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus Diabetes Metab Res Rev 17 2001 164 174
32. L. Rossetti, A. Giaccari, and R.A. DeFronzo Glucose toxicity Diabetes Care 13 1990 610 630
33. V. Grill, and A. Bjorklund Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities Cell Mol Life Sci 57 2000 429 440
34. M. Pirro, P. Mauriege, and A. Tchernof Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study Atherosclerosis 160 2002 377 384